Development of novel CLK1 inhibitors as potential drugs for treatment of Chikungunya virus infections
Livnah, O., Domovich, Y., Bracher, F., Aiger, C.To be published.
Experimental Data Snapshot
Starting Model: experimental
View more details
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Dual specificity protein kinase CLK1 | 337 | Homo sapiens | Mutation(s): 0  Gene Names: CLK1, CLK EC: 2.7.12.1 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P49759 (Homo sapiens) Explore P49759  Go to UniProtKB:  P49759 | |||||
PHAROS:  P49759 GTEx:  ENSG00000013441  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P49759 | ||||
Sequence AnnotationsExpand | |||||
|
Ligands 1 Unique | |||||
---|---|---|---|---|---|
ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
V5T (Subject of Investigation/LOI) Query on V5T | B [auth A] | 4-(1~{H}-indol-3-yl)pyrimidin-2-amine C12 H10 N4 QNMZWFNNJMGJPU-UHFFFAOYSA-N |
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 68.43 | α = 90 |
b = 68.43 | β = 90 |
c = 284.45 | γ = 120 |
Software Name | Purpose |
---|---|
REFMAC | refinement |
MOSFLM | data reduction |
XSCALE | data scaling |
MOLREP | phasing |
Funding Organization | Location | Grant Number |
---|---|---|
German-Israeli Foundation for Research and Development | Israel | i-1453-207.9/2018 |